JUN 25, 2026 · REGULATORY APPROVAL
FDA approval: Ferric Carboxymaltose
U.S. Food and Drug Administration
FDA approval of a generic ferric carboxymaltose formulation; regulatory action confirming bioequivalence or abbreviated pathway clearance, not a clinical efficacy trial.
Reported
Formulation strength1 GM IRON/20ML (50MG IRON/ML)
Route of administrationINTRAVENOUS
Approval date2026-06-25